首页|Affiliated Hospital of Southwest Medical University Reports Findings in Artificial Intelligence (Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging)
Affiliated Hospital of Southwest Medical University Reports Findings in Artificial Intelligence (Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
New research on Artificial Intelligence is the subject of a report. According to news reporting originating from Sichuan, People’s Republic of China, by NewsRx correspondents, research stated, “Cholangiocarcinoma (CCA) is a highly aggressive hepatobiliary malignancy, second only to hepatocellular carcinoma in prevalence. Despite surgical treatment being the recommended method to achieve a cure, it is not viable for patients with advanced CCA.”
SichuanPeople’s Republic of ChinaAsiaArtificial IntelligenceCancerCholangiocarcinomaDrugs and TherapiesEmerging TechnologiesHealth and MedicineImmunotherapyMachine LearningOncologyTherapy
NETL
NSTL
